Is UnitedHealth Finding a Better Path to Medicare Advantage Growth?

UnitedHealth Group Incorporated UNH is taking a more disciplined approach to Medicare Advantage (MA), with profitability increasingly taking precedence over membership expansion. This shift comes as elevated medical costs continue to challenge the industry and pressure insurers to reassess pricing, benefits and market participation.

UnitedHealthcare expects 2026 MA enrollment to decline by approximately 1.1 million members, reflecting targeted exits from unprofitable plans. However, Medicare margins are now expected to finish the year above 3%. The improvement reflects tighter benefit design, pricing actions and a more favorable membership mix, while the company expects Medicare medical cost trends to come below the initial estimate of near 10%.

Cost-control initiatives are also becoming an important part of the strategy. Network curation, care management, affordability programs and greater use of value-based care are helping contain medical expenses. Favorable claims experience and a lighter respiratory season have provided additional support. UNH’s consolidated medical care ratio improved to 86.7% in the second quarter from 89.4% a year ago. The company raised its 2026 adjusted EPS outlook to $19.50-$20. For 2027, benefit planning remains centered on current cost trends, with adjustments to benefits and selective market participation aimed at maintaining margin stability.

The strategy could place UnitedHealth on a more sustainable MA growth path, even as near-term enrollment remains under pressure. Improving medical cost trends and a gradual recovery in membership could strengthen the economics of UnitedHealth’s MA business. If these trends persist, UNH could emerge from its current reset with a more profitable MA business and a stronger foundation for long-term growth.

How Are Competitors Faring?

Some of UNH’s major competitors in the medical space are Humana Inc. HUM and Elevance Health, Inc. ELV.

Humana remains heavily exposed to Medicare Advantage, making medical cost control and benefit optimization critical to its outlook. HUM is focusing on pricing, network management and operating efficiencies to restore margins while navigating membership pressure and elevated utilization across its MA portfolio.

Elevance Health is sharpening its Medicare Advantage strategy by prioritizing profitable growth over broad membership gains. Portfolio repositioning, disciplined plan design and a stronger focus on D-SNP and HMO offerings are improving performance, while care management and favorable claims trends support ELV’s path toward at least a 2% operating margin in 2026.

UnitedHealth’s Price Performance, Valuation & Estimates

Shares of UNH have gained 25.2% in the past year compared with the industry’s growth of 21.4%.

Image Source: Zacks Investment Research

From a valuation standpoint, UnitedHealth trades at a forward price-to-earnings ratio of 17.96, above the industry average of 15.60. UNH carries a Value Score of B.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for UnitedHealth’s 2026 earnings is pegged at $19.69 per share, implying 20.4% growth from the year-ago period.

Image Source: Zacks Investment Research

UNH stock currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Beyond Nvidia: AI's Second Wave Is Here

The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research